| Raymond Craig Collins, MD | |
|
3655 Mitchell St, Loris, SC 29569-2827 | |
| (843) 716-7000 | |
| (706) 660-9390 |
| Full Name | Raymond Craig Collins |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 3655 Mitchell St, Loris, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831172493 | NPI | - | NPPES |
| 208037 | Medicaid | SC | |
| GP2672 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 20803 (South Carolina) | Secondary |
| 207L00000X | Anesthesiology | 20803 (South Carolina) | Primary |
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140304001021 |
News Archive
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States, The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.
Scientists have developed a new tissue 'scaffold' technology that could one day enable the engineering of large organs. Research led by the Universities of Bristol and Liverpool has shown that it is possible to combine cells with a special scaffold to produce living tissue in the laboratory. It is hoped this can then be implanted into patients as a way of replacing diseased parts of the body.
Researchers from The Cancer Institute of New Jersey (CINJ) are converging on Denver for the 100th Annual Meeting of the American Association for Cancer Research (AACR) to share their findings on a combined treatment targeting breast cancer that is stimulated by the hormone estrogen (estrogen receptive positive).
Long-term supplementation with dietary antioxidants has beneficial effects on sugar and fat metabolism, blood pressure and arterial flexibility in patients with multiple cardiovascular risk factors. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism report these positive results in a randomized controlled trial of combined vitamin C, vitamin E, coenzyme Q10 and selenium capsules.
Mayo Clinic researchers report that most women who have a contralateral (opposite to cancerous breast) prophylactic mastectomy (CPM) are satisfied and would elect this procedure again. Satisfaction with CPM was studied an average of 10 years after the procedure was done. The findings were published online Oct. 3 in the Journal of Clinical Oncology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raymond Craig Collins, MD Po Box 602437, Charlotte, NC 28260-2437 Ph: (800) 329-9156 | Raymond Craig Collins, MD 3655 Mitchell St, Loris, SC 29569-2827 Ph: (843) 716-7000 |
News Archive
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States, The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.
Scientists have developed a new tissue 'scaffold' technology that could one day enable the engineering of large organs. Research led by the Universities of Bristol and Liverpool has shown that it is possible to combine cells with a special scaffold to produce living tissue in the laboratory. It is hoped this can then be implanted into patients as a way of replacing diseased parts of the body.
Researchers from The Cancer Institute of New Jersey (CINJ) are converging on Denver for the 100th Annual Meeting of the American Association for Cancer Research (AACR) to share their findings on a combined treatment targeting breast cancer that is stimulated by the hormone estrogen (estrogen receptive positive).
Long-term supplementation with dietary antioxidants has beneficial effects on sugar and fat metabolism, blood pressure and arterial flexibility in patients with multiple cardiovascular risk factors. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism report these positive results in a randomized controlled trial of combined vitamin C, vitamin E, coenzyme Q10 and selenium capsules.
Mayo Clinic researchers report that most women who have a contralateral (opposite to cancerous breast) prophylactic mastectomy (CPM) are satisfied and would elect this procedure again. Satisfaction with CPM was studied an average of 10 years after the procedure was done. The findings were published online Oct. 3 in the Journal of Clinical Oncology.
› Verified 2 days ago
Ramiro Jay Godines, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3655 Mitchell St, Loris, SC 29569 Phone: 843-716-7000 Fax: 706-660-9390 | |
Frederick William Bellamy, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3655 Mitchell St, Loris, SC 29569 Phone: 843-716-7000 Fax: 706-660-9390 |